NCT03110666View on ClinicalTrials.gov

Treatment for Knee Osteoarthritis With Injections of BMC at the Bone-cartilage Interface. Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 14, 2016

Primary Completion Date

November 25, 2018

Study Completion Date

May 31, 2022

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

Injection of autologous concentrated bone marrow aspirate

Percutaneous injections at the bone-cartilage interface (distal femur and proximal tibia)

Trial Locations (1)

40136

Rizzoli Orthopaedic Institute, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER

NCT03110666 - Treatment for Knee Osteoarthritis With Injections of BMC at the Bone-cartilage Interface. Pilot Study | Biotech Hunter | Biotech Hunter